Acumen Pharmaceuticals, Inc. (ABOS) — Operating Cash Flow
| Fiscal Year | Operating Cash Flow | Change YoY |
|---|---|---|
| 2025 | -$115.54M | -34.0% |
| 2024 | -$86.22M | -100.2% |
| 2023 | -$43.06M | -22.5% |
| 2022 | -$35.15M | -95.7% |
| 2021 | -$17.96M | -141.1% |
| 2020 | -$7.45M | — |
| Fiscal Year | Operating Cash Flow | Change YoY |
|---|---|---|
| 2025 | -$115.54M | -34.0% |
| 2024 | -$86.22M | -100.2% |
| 2023 | -$43.06M | -22.5% |
| 2022 | -$35.15M | -95.7% |
| 2021 | -$17.96M | -141.1% |
| 2020 | -$7.45M | — |